Basal cell carcinoma: genes and variants
Explore variant evidence for Basal cell carcinoma across 12 analyzed proteins (SMO, TP53, PTCH1, BACH2, CTLA4 and 7 more). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 116 variants of uncertain significance and 61 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-22. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Basal cell carcinoma
SMO: Protein smoothened
It transmits Hedgehog signals across the membrane after inhibition by PTCH1 is relieved, activating GLI-dependent developmental transcription. Activating variants or upstream pathway loss can drive basal-cell carcinoma, medulloblastoma, and other Hedgehog-dependent tumors.
2 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in SMO have source records linked to Basal cell carcinoma. Association strength is not clinical gene validity.
TP53: Cellular tumor antigen p53
It coordinates transcriptional responses to DNA damage and other cellular stresses, promoting cell-cycle arrest, senescence, DNA repair, or apoptosis when appropriate. Loss of this tumor-suppressive control is one of the most common events in cancer, while germline pathogenic variants cause Li-Fraumeni syndrome.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TP53 have source records linked to Basal cell carcinoma. Association strength is not clinical gene validity.
PTCH1: Protein patched homolog 1
It suppresses Smoothened in the absence of Hedgehog ligands and thereby keeps Hedgehog developmental signaling inactive until an appropriate signal is received. Germline loss-of-function variants cause Gorlin syndrome, while somatic pathway activation drives basal-cell carcinoma and other tumors.
0 ClinVar pathogenic / likely pathogenic and 172 uncertain variants in PTCH1 have source records linked to Basal cell carcinoma. Association strength is not clinical gene validity.
BACH2: Transcription regulator protein BACH2
It controls transcriptional programs that balance lymphocyte differentiation, immune tolerance, and effector-cell development. Haploinsufficiency can cause immunodeficiency with autoimmunity, and common variation influences susceptibility to several autoimmune diseases.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in BACH2 have source records linked to Basal cell carcinoma. Association strength is not clinical gene validity.
CTLA4: Cytotoxic T-lymphocyte protein 4
It restrains T-cell activation by competing with CD28 for CD80 and CD86 and by delivering inhibitory signals after immune activation. Haploinsufficiency causes immune dysregulation with autoimmunity and lymphoproliferation, while therapeutic blockade enhances antitumor immunity.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CTLA4 have source records linked to Basal cell carcinoma. Association strength is not clinical gene validity.
IRF4: Interferon regulatory factor 4
It controls differentiation and function of B cells, plasma cells, T cells, and other immune lineages in a context-dependent manner. Germline variants can cause immunodeficiency, while rearrangements or abnormal expression drive several lymphoid malignancies.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IRF4 have source records linked to Basal cell carcinoma. Association strength is not clinical gene validity.
KRT5: Keratin, type II cytoskeletal 5
It pairs with keratin 14 to form the primary intermediate-filament scaffold of basal epidermal keratinocytes. Dominant pathogenic variants are a major cause of epidermolysis bullosa simplex, while other alleles can cause pigmentary disorders such as Dowling-Degos disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KRT5 have source records linked to Basal cell carcinoma. Association strength is not clinical gene validity.
MYCN: N-myc proto-oncogene protein
It drives transcriptional programs for growth, metabolism, and proliferation during neural and other embryonic development. Amplification is a major adverse prognostic feature in neuroblastoma, while germline dysregulation can cause developmental syndromes with abnormal growth.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in MYCN have source records linked to Basal cell carcinoma. Association strength is not clinical gene validity.
OCA2: P protein
It supports chloride conductance in melanosomes, helping establish the pH needed for tyrosinase activity and melanin production. Biallelic loss-of-function variants cause oculocutaneous albinism type 2, while common regulatory variation contributes to differences in eye, skin, and hair pigmentation.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in OCA2 have source records linked to Basal cell carcinoma. Association strength is not clinical gene validity.
TLR7: Toll-like receptor 7
It detects single-stranded viral RNA in endosomes and drives type I interferon and inflammatory responses, particularly in plasmacytoid dendritic cells and B cells. Loss-of-function variants can predispose to severe viral infection, whereas gain-of-function variants cause immune dysregulation and autoimmunity.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TLR7 have source records linked to Basal cell carcinoma. Association strength is not clinical gene validity.
XPA: DNA repair protein complementing XP-A cells
It verifies bulky DNA lesions and organizes the nucleotide-excision-repair machinery around damaged sites. Biallelic loss-of-function variants cause xeroderma pigmentosum group A with extreme ultraviolet sensitivity, early skin cancers, and often progressive neurologic disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in XPA have source records linked to Basal cell carcinoma. Association strength is not clinical gene validity.
RASA1: Ras GTPase-activating protein 1
It accelerates hydrolysis of RAS-GTP and therefore limits RAS-MAPK signaling downstream of growth-factor receptors. Haploinsufficiency causes capillary malformation-arteriovenous malformation syndrome and related fast-flow vascular anomalies.
2 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in RASA1 have source records linked to Basal cell carcinoma. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Basal cell carcinoma
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| TP53 L130P | 130 | DNA binding | Pathogenic / likely pathogenic (★★) |
| RASA1 R398L | 398 | SH2 2 | Pathogenic / likely pathogenic |
| RASA1 K400E | 400 | SH2 2 | Pathogenic / likely pathogenic |
| SMO W535L | 535 | Transmembrane | Pathogenic / likely pathogenic |
| SMO R562Q | 562 | Interaction with BBS5 and BBS7 | Pathogenic / likely pathogenic |
Same protein, different disease
- Congenital hypothalamic hamartoma syndrome also has ClinVar records linked to SMO variants; they fall mostly in different places as the Basal cell carcinoma variants (6 pathogenic / likely pathogenic).
- Li-Fraumeni syndrome also has ClinVar records linked to TP53 variants; they fall mostly in different places as the Basal cell carcinoma variants (188 pathogenic / likely pathogenic).
- Adrenocortical carcinoma, hereditary also has ClinVar records linked to TP53 variants; they fall mostly in different places as the Basal cell carcinoma variants (23 pathogenic / likely pathogenic).
- Acute myeloid leukemia also has ClinVar records linked to TP53 variants; they fall mostly in different places as the Basal cell carcinoma variants (6 pathogenic / likely pathogenic).
- Hereditary breast ovarian cancer syndrome also has ClinVar records linked to TP53 variants; they fall mostly in different places as the Basal cell carcinoma variants (6 pathogenic / likely pathogenic).
- Hereditary breast cancer also has ClinVar records linked to TP53 variants; they fall mostly in different places as the Basal cell carcinoma variants (5 pathogenic / likely pathogenic).
Diseases related to Basal cell carcinoma
- Hypothyroidism, also linked to BACH2, CTLA4 and IRF4
- Melanoma, also linked to CTLA4, IRF4 and OCA2
- Acute myeloid leukemia, also linked to SMO and TP53
- Multiple myeloma, also linked to IRF4 and TP53
- Type 1 diabetes mellitus, also linked to BACH2 and CTLA4
- Hepatocellular carcinoma, also linked to CTLA4 and TP53
- Medulloblastoma, also linked to PTCH1 and SMO
- Systemic lupus erythematosus, also linked to CTLA4 and TLR7
- Li-Fraumeni syndrome, also linked to TP53
- Ovarian cancer, also linked to PTCH1
- Tyrosinase-positive oculocutaneous albinism, also linked to OCA2
- Xeroderma pigmentosum, also linked to XPA
Frequently asked questions
Which genes have records linked to Basal cell carcinoma?
This view contains 12 analyzed proteins: SMO, TP53, PTCH1, BACH2, CTLA4 and 7 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 116 variants of uncertain significance and 61 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 184 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center